United States· US:82959-111_b96b0022-c4f5-458e-aa7e-21c62ac5cd8c
RYTELO
A imetelstat product containing imetelstat sodium, registered in United States by Geron Corporation. The same ATC class is registered in 8 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Imetelstat is registered in 8 of 19 countries.
Countries holding a registration under ATC L01XX80 (imetelstat), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Imetelstat · ATC L01XX80
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- IMETELSTAT SODIUM
- Manufacturer
- Geron Corporation
- Country
- United States (US)
- ATC code
- L01XX80
- ATC class
- Imetelstat
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1182959111011 VIAL, SINGLE-DOSE in 1 CARTON (82959-111-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
- ndc1182959-111-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Imetelstat in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumRytelo 188 mgGeron Netherlands
- CzechiaRYTELOGeron Netherlands B.V., Amsterdam
- FinlandRyteloGeron Netherlands B.V.
- IrelandRytelo 188 mg powder for concentrate for solution for infusionGeron Netherlands B.V.
- IcelandRyteloGeron Netherlands B.V.
- NetherlandsRytelo 188 mg poeder voor concentraat voor oplossing voor infusieGeron Netherlands B.V.
- PolandRyteloGeron Netherlands B.V.
- SwedenRytelo 188 mg Pulver till koncentrat till infusionsvätska, lösningGeron Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rytelo
- Liechtenstein · Rytelo
- Norway · Rytelo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cb27fa0a-cd7e-4eaa-b136-7160933d875e GET /v1/drugs/cb27fa0a-cd7e-4eaa-b136-7160933d875e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "188",
"substance": "IMETELSTAT SODIUM",
"productndc": "82959-111",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA217779",
"marketing_category": "NDA"
}See everything about imetelstat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.